NCT03063723View on ClinicalTrials.gov

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

December 1, 2016

Conditions
Chronic Hepatitis C (Disorder)
Interventions
DRUG

Ledipasvir-Sofosbuvir

8 CHC patients were treated with Sofosbuvir (400mg, qd)/Ledipasvir (90mg, qd) for 12 weeks

DRUG

Daclatasvir-Sofosbuvir

7 CHC patients were treated with Sofosbuvir (400mg, qd)/Daclatasvir (60mg,qd) for 12 weeks.

All Listed Sponsors
lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT03063723 - Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs | Biotech Hunter | Biotech Hunter